Simvastatin treatment is associated with improvement in coronary endothelial function and decreased cytokine activation in patients after heart transplantation
Michael Weis, MD*,
Sinan Pehlivanli, MD ,
Bruno M. Meiser, MD and
Wolfgang von Scheidt, MD
* Stanford University Medical School, Falk Cardiovascular Research Center, Stanford, California, USA
Division of Cardiology, University Hospital Grosshadern, Ludwig-Maximilians University of Munich, Munich, Germany
Division of Cardiovascular Surgery, University Hospital Grosshadern, Ludwig-Maximilians University of Munich, Munich, Germany

View larger version (14K):
[in a new window]
|
Figure 1 Epicardial endothelium-dependent vasomotor response. Epicardial diameter change in response to intracoronary acetylcholine (ACh). Group 1 = patients with hypercholesterolemia adequately controlled; group 2 = patients with hypercholesterolemia inadequately controlled; group 3 = patients without hypercholesterolemia. *p < 0.01 vs. group 2; **p < 0.05 vs. group 2.
|
|

View larger version (13K):
[in a new window]
|
Figure 2 Microvascular endothelium-dependent vasomotor response. Coronary flow velocity increase in response to intracoronary acetylcholine (ACh). Group 1 = patients with hypercholesterolemia adequately controlled; group 2 = patients with hypercholesterolemia inadequately controlled; group 3 = patients without hypercholesterolemia. *p < 0.05 vs. groups 1 and 3.
|
|
|